Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azvudine and Tenofovir Alafenamide Fumarate Interaction Study
NCT07002268Phase 1Completed
- Sponsor
- Genuine Biotech
- Start
- Mar 2022
- Primary completion
- May 2022
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of azvudine (3 arms), sponsored by Genuine Biotech. Started Mar 2022; status: completed.
02
Drugs
azvudine
Beyond the preview
Go deeper on NCT07002268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07002268.